statistiche ricercatore

statistiche per ROGLIANI, PAOLA

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 64036
EU - Europa 2609
AS - Asia 1783
SA - Sud America 21
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 68460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 64020
CN - Cina 994
KR - Corea 731
UA - Ucraina 616
PL - Polonia 460
FR - Francia 398
DE - Germania 369
IT - Italia 355
FI - Finlandia 147
GB - Regno Unito 134
RU - Federazione Russa 60
NL - Olanda 21
JP - Giappone 17
IN - India 14
CA - Canada 13
BR - Brasile 12
SE - Svezia 12
RO - Romania 8
ES - Italia 7
KG - Kirghizistan 7
GR - Grecia 6
EU - Europa 5
TW - Taiwan 5
AU - Australia 4
CO - Colombia 4
AR - Argentina 3
CH - Svizzera 3
JO - Giordania 3
MY - Malesia 3
RS - Serbia 3
VN - Vietnam 3
IS - Islanda 2
MK - Macedonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
GT - Guatemala 1
HR - Croazia 1
IE - Irlanda 1
IR - Iran 1
LB - Libano 1
PH - Filippine 1
TH - Thailandia 1
TR - Turchia 1
Totale 68460
Salva come PNG Salva come JPEG
Città #
Wilmington 19678
Houston 18263
Woodbridge 18017
Fairfield 2261
Ann Arbor 1292
Seattle 1033
Ashburn 996
Cambridge 791
Dearborn 461
Kraków 456
Jacksonville 385
Beijing 310
Zhengzhou 279
Rome 188
Hangzhou 72
Shanghai 65
Redwood City 56
Menlo Park 49
Palo Alto 46
Jinan 42
Milan 39
Nanjing 37
Hefei 32
Kunming 25
Guangzhou 24
Verona 24
Detroit 21
Mountain View 21
Seoul 19
Chicago 18
Norwalk 18
Saint Petersburg 17
Phoenix 13
University Park 12
Wuhan 12
Nanchang 11
Chengdu 10
Los Angeles 10
San Jose 6
Auburn Hills 5
Fuzhou 5
Hamilton 5
Hebei 5
Latina 5
Shenyang 5
Thessaloníki 5
Chaoyang 4
Chongqing 4
Iasi 4
Köln 4
Ottawa 4
Tallahassee 4
Xian 4
Belgrade 3
Berkeley 3
Chaah 3
Changchun 3
Forlì 3
Hanoi 3
Napoli 3
Ningbo 3
Nürnberg 3
Raleigh 3
Saponara 3
Simi Valley 3
Stony Brook 3
Ancona 2
Aurora 2
Baulkham Hills 2
Bogotá 2
Bremen 2
Caserta 2
Costa Mesa 2
Durham 2
Formello 2
Forst 2
Frankfurt Am Main 2
Guiyang 2
Harbin 2
Lausanne 2
Leeds 2
Little Rock 2
London 2
Monterrey 2
Moscow 2
Nanning 2
Nizhniy Novgorod 2
Polska 2
Saint-jérôme 2
Shaoxing 2
Taipei 2
Taizhou 2
Acqui Terme 1
Alghero 1
Augsburg 1
Avon 1
Bangalore 1
Bangkok 1
Baotou 1
Baracaldo 1
Totale 65271
Salva come PNG Salva come JPEG
Nome #
An update on the pharmacotherapeutic management of lower respiratory tract infections 462
Thoracoscopic reduction pneumoplasty for severe emphysema: Do pleural adhesions affect outcome? 416
Awake thoracoscopic biopsy of interstitial lung disease 415
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 413
Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules 408
Interaction between corticosteroids and muscarinic antagonists in human airways 406
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 404
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 404
Unilateral thoracoscopic reduction pneumoplasty for asymmetric emphysema 402
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 401
Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma 398
An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network 398
Completion lobectomy after bilateral lung volume reduction for emphysema: Salvage option or fancy? 397
null 397
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation 395
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 393
Optimizing drug delivery in COPD: The role of inhaler devices 392
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 390
Tiotropium formulations and safety: a network meta-analysis 388
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 387
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease 387
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab 386
High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. 381
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 381
Bronchodilator therapy for chronic cough 380
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease 379
Asthma and comorbid medical illness. 379
Glucagon-like peptide 1 receptor: A novel pharmacological target for treating human bronchial hyperresponsiveness 379
Vats lung reduction in patients with advanced emphysema 378
How many systemic reactions to skin prick tests could be preventable in defined conditions? 378
Treatment options for moderate-to-very severe chronic obstructive pulmonary disease 378
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 378
Effect of lung volume reduction surgery for severe emphysema on right ventricular function 377
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 376
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. 375
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 375
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 374
Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase 372
Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”? 371
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298 371
Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease 370
QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease 369
Occupational allergy to horse allergens: More than exposure to horses! 369
Is allergic sensitization to siberian hamster preventable in high-risk individuals who are already sensitized or exposed to furry animals? 368
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases 368
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease 367
New Treatments for COPD in the Elderly 367
Can pet keeping be considered the only criterion of exposure to cat/dog allergens in the first year of life? 367
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways 366
Occupational allergy to horse allergens: More than exposure to horses! 364
Minimalist video-assisted thoracic surgery biopsy of mediastinal tumors 364
Role of muscarinic antagonists in asthma therapy 364
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 362
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity. 361
Bacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD. 361
Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? 360
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi 360
Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi 358
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis 358
Results of unilateral lung volume reduction surgery in patients with distinct heterogeneity of emphysema between lungs 358
Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules 357
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema 356
Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? 355
Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: A point of view 355
Asthma and comorbid medical illness 354
Completion lobectomy after bilateral lung volume reduction for emphysema: salvage option or fancy? 354
Urgent awake thoracoscopic treatment of retained haemothorax associated with respiratory failure 352
Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience 351
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 350
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 350
Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone 347
The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators 347
Impact of pulmonary vascular volume on mortality in IPF: Is it time to reconsider the role of vasculature in disease pathogenesis and progression? 347
null 347
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity 346
Metabolic syndrome and risk of pulmonary involvement 346
Influence of ethnicity on response to asthma drugs 345
Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study 345
Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study 344
Comorbidities of asthma 343
Umeclidinium for the treatment of chronic obstructive pulmonary disease 343
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? 343
Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome? 342
Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis 341
Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement 341
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 340
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 340
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi 340
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease 338
The Challenges of Precision Medicine in COPD 338
The complex care of severe emphysema: role of awake lung volume reduction surgery 337
Can the presence of cat/dog at home be considered the only criterion of exposure to cat/dog allergens? A likely underestimated bias in clinical practice and in large epidemiological studies 337
The effect of indacaterol during an acute exacerbation of COPD 336
Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD 334
Awake videothoracoscopic biopsy of diffuse lung disease. Effects on pulmonary function and oxygenation 334
Dog allergen immunotherapy and allergy to furry animals 332
Indacaterol for the treatment of chronic obstructive pulmonary disease 331
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 331
Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives 331
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 330
Totale 36632
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69233
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2015/201695 0000 00 062 96810
2016/20174139 356170133 4332 522567 570556743744
2017/201812734 8348412239732 1849780 718817 11128781044890
2018/201916483 876824800831 7351462 14731475 1549196723152176
2019/202023421 1871179214522389 22562548 21102160 2138178713951523
2020/202112230 1442156115041555 13871414 20651302 0000
Totale 69233
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2021